3-phosphoglycerate has been researched along with Neoplasms in 8 studies
3-phosphoglycerate : An organic anion obtained by deprotonation of at least one of the acidic groups of 3-phosphoglyceric acid.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We used datasets from the Cancer Cell Line Encyclopedia (CCLE) phase II project and treated metabolomic data as tensor predictors and data on gene expression of metabolic enzymes as confounding covariates." | 1.91 | Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers. ( Huang, TH; Li, CI; Lin, PC; Shen, MR; Tsai, YS; Yeh, YM, 2023) |
| "It is unclear how cancer cells coordinate glycolysis and biosynthesis to support rapidly growing tumors." | 1.38 | Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. ( Alečković, M; Arellano, ML; Boggon, TJ; Chen, GZ; Chen, J; Dai, Q; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Jin, P; Kang, HB; Kang, S; Kang, Y; Khoury, HJ; Khuri, FR; Lee, BH; LeRoy, G; Lonial, S; Luan, CH; Muller, S; Owonikoko, TK; Seo, JH; Shan, C; Shin, DM; Sudderth, JA; Xie, J; Ye, K; Zhang, L; Zhou, L, 2012) |
| "Proliferating cells, including cancer cells, require altered metabolism to efficiently incorporate nutrients such as glucose into biomass." | 1.36 | Evidence for an alternative glycolytic pathway in rapidly proliferating cells. ( Amador-Noguez, D; Asara, JM; Cantley, LC; Christofk, HR; Heffron, GJ; Locasale, JW; Rabinowitz, JD; Sharfi, H; Swanson, KD; Vander Heiden, MG; Wagner, G, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, CI | 1 |
| Yeh, YM | 1 |
| Tsai, YS | 1 |
| Huang, TH | 1 |
| Shen, MR | 1 |
| Lin, PC | 1 |
| Jin, C | 1 |
| Zhu, X | 1 |
| Wu, H | 1 |
| Wang, Y | 3 |
| Hu, X | 1 |
| Fareed, MM | 1 |
| El-Esawi, MA | 1 |
| El-Ballat, EM | 1 |
| Batiha, GE | 1 |
| Rauf, A | 1 |
| El-Demerdash, FM | 1 |
| Alhumaydhi, FA | 1 |
| Alsagaby, SA | 1 |
| Sharif, F | 1 |
| Rasul, A | 1 |
| Ashraf, A | 1 |
| Hussain, G | 1 |
| Younis, T | 1 |
| Sarfraz, I | 1 |
| Chaudhry, MA | 1 |
| Bukhari, SA | 1 |
| Ji, XY | 1 |
| Selamoglu, Z | 1 |
| Ali, M | 1 |
| Hitosugi, T | 2 |
| Zhou, L | 2 |
| Fan, J | 2 |
| Elf, S | 2 |
| Zhang, L | 2 |
| Xie, J | 2 |
| Gu, TL | 2 |
| Alečković, M | 2 |
| LeRoy, G | 2 |
| Kang, Y | 2 |
| Kang, HB | 2 |
| Seo, JH | 2 |
| Shan, C | 2 |
| Jin, P | 2 |
| Gong, W | 1 |
| Lonial, S | 2 |
| Arellano, ML | 2 |
| Khoury, HJ | 2 |
| Chen, GZ | 2 |
| Shin, DM | 2 |
| Khuri, FR | 2 |
| Boggon, TJ | 2 |
| Kang, S | 2 |
| He, C | 2 |
| Chen, J | 2 |
| Cai, WS | 1 |
| Chen, L | 1 |
| Wang, G | 1 |
| Vander Heiden, MG | 1 |
| Locasale, JW | 1 |
| Swanson, KD | 1 |
| Sharfi, H | 1 |
| Heffron, GJ | 1 |
| Amador-Noguez, D | 1 |
| Christofk, HR | 1 |
| Wagner, G | 1 |
| Rabinowitz, JD | 1 |
| Asara, JM | 1 |
| Cantley, LC | 1 |
| Dai, Q | 1 |
| Sudderth, JA | 1 |
| DeBerardinis, RJ | 1 |
| Luan, CH | 1 |
| Muller, S | 1 |
| Owonikoko, TK | 1 |
| Lee, BH | 1 |
| Ye, K | 1 |
1 review available for 3-phosphoglycerate and Neoplasms
| Article | Year |
|---|---|
Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
Topics: Cell Proliferation; Glyceric Acids; Glycolysis; Humans; Molecular Targeted Therapy; Neoplasms; Phosp | 2019 |
7 other studies available for 3-phosphoglycerate and Neoplasms
| Article | Year |
|---|---|
Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers.
Topics: Biomarkers, Tumor; Gene Expression; Glyceric Acids; Humans; Microsatellite Instability; Neoplasms; S | 2023 |
Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells.
Topics: A549 Cells; Diphosphoglyceric Acids; Glucose; Glyceric Acids; Glycolysis; HeLa Cells; Humans; Kineti | 2020 |
Topics: Antineoplastic Agents; Arginine; Binding Sites; Cell Movement; Cell Proliferation; Computer Simulati | 2021 |
Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
Topics: 2,3-Diphosphoglycerate; Amino Acid Sequence; Animals; Cell Line, Tumor; Cell Proliferation; Enzyme S | 2013 |
Molecular dynamics simulation reveals how phosphorylation of tyrosine 26 of phosphoglycerate mutase 1 upregulates glycolysis and promotes tumor growth.
Topics: 2,3-Diphosphoglycerate; Algorithms; Amino Acid Sequence; Glyceric Acids; Glycolysis; Humans; Hydroge | 2017 |
Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Line, Tumor; Cell Proliferation; Female; Glucose; G | 2010 |
Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
Topics: Animals; Binding, Competitive; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Gene Knockdo | 2012 |